NURS 6630 Final Exam (2024) Walden University – Question and
Answers
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs
to manage the top-down cortical control and the excessive drive from striatal hyperactivity?
C. Antipsychotics
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
D. Second-generation, atypical antipsychotics
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of
atypical antipsychotics?
C. The doses are based on achieving 60% D2 receptor occupancy.
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects.
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
C. Titrating the dose by increasing it every 5–7 days
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will
the PMHNP select?
A. Lithium (Lithane)
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on
their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which
medication will the PMHNP will most likely prescribe?
A. Strattera
The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
A. 8-year-old patient
, NURS 6630 Final Exam (2024) Walden University – Question and
Answers
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
C. The medication can affect your blood pressure.
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the
PMHNP include in the teaching?
A. The second dose should be taken at lunch.
A young patient is prescribed Vyvanse. During the follow-up appointment, which comment made
by the patient makes the PMHNP think that the dosing is being done incorrectly?
A. “I take my pill at breakfast.” B. “I am unable to fall asleep at night.” C. “I feel okay all day
long.” D. “I am not taking my pill at lunch.”
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What
does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch. B. The patient will have one or two doses a
day. C. The patient will take a pill every 17 hours. D. The dosing should be done in the morning
and at night.
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
A. The child will be prescribed 2.5 mg. B. The child will be prescribed a 10-mg tablet. C. The
child’s dose will increase by 2.5 mg every other week. D. The child will take 10–40 mg, daily.
A patient is being prescribed bupropion and is concerned about the side effects. What will the
PMHNP tell the patient regarding bupropion?
A. Weight gain is not unusual. B. Sedation may be common. C. It can cause cardiac
arrhythmias. D. It may amplify fatigue.
Which patient will receive a lower dose of guanfacine?
A. Patient who has congestive heart failure B. Patient who has cerebrovascular disease C. Patient
who is pregnant D. Patient with kidney disease
Answers
What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs
to manage the top-down cortical control and the excessive drive from striatal hyperactivity?
C. Antipsychotics
The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic
behaviors with poor impulse control and aggression. Of the available treatments, which can help
temper some of the adverse effects or symptoms that are normally caused by D2 antagonism?
D. Second-generation, atypical antipsychotics
The PMHNP is discussing dopamine D2 receptor occupancy and its association with aggressive
behaviors in patients with the student. Why does the PMHNP prescribe a standard dose of
atypical antipsychotics?
C. The doses are based on achieving 60% D2 receptor occupancy.
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?
A. There is too high a risk of serious adverse side effects.
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient?
C. Titrating the dose by increasing it every 5–7 days
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive and
impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood stabilizer will
the PMHNP select?
A. Lithium (Lithane)
The parents of a 7-year-old patient with ADHD are concerned about the effects of stimulants on
their child. The parents prefer to start pharmacological treatment with a non-stimulant. Which
medication will the PMHNP will most likely prescribe?
A. Strattera
The PMHNP understands that slow-dose extended release stimulants are most appropriate for
which patient with ADHD?
A. 8-year-old patient
, NURS 6630 Final Exam (2024) Walden University – Question and
Answers
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What should the
PMHNP include when discussing the side effects with the patient?
C. The medication can affect your blood pressure.
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will the
PMHNP include in the teaching?
A. The second dose should be taken at lunch.
A young patient is prescribed Vyvanse. During the follow-up appointment, which comment made
by the patient makes the PMHNP think that the dosing is being done incorrectly?
A. “I take my pill at breakfast.” B. “I am unable to fall asleep at night.” C. “I feel okay all day
long.” D. “I am not taking my pill at lunch.”
A 14-year-old patient is prescribed Strattera and asks when the medicine should be taken. What
does the PMHNP understand regarding the drug’s dosing profile?
A. The patient should take the medication at lunch. B. The patient will have one or two doses a
day. C. The patient will take a pill every 17 hours. D. The dosing should be done in the morning
and at night.
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing practices
when she prescribes the following dose:
A. The child will be prescribed 2.5 mg. B. The child will be prescribed a 10-mg tablet. C. The
child’s dose will increase by 2.5 mg every other week. D. The child will take 10–40 mg, daily.
A patient is being prescribed bupropion and is concerned about the side effects. What will the
PMHNP tell the patient regarding bupropion?
A. Weight gain is not unusual. B. Sedation may be common. C. It can cause cardiac
arrhythmias. D. It may amplify fatigue.
Which patient will receive a lower dose of guanfacine?
A. Patient who has congestive heart failure B. Patient who has cerebrovascular disease C. Patient
who is pregnant D. Patient with kidney disease
